Lowenstein has advised Matinas in the sale of Matinas BioPharma Nanotechnologies to Azurity Pharmaceuticals. Matinas BioPharma has entered into a definitive stock purchase agreement to sell...
Azurity Pharmaceuticals to Acquire Matinas BioPharma Nanotechnologies
Matinas BioPharma and GH Power Announce Business Combination to Create NYSE-listed Clean Energy and Critical Minerals Company
Lowenstein Sandler LLP has represented Matinas BioPharma Holdings, Inc. in its business combination agreement with GH Power, Inc. Matinas BioPharma Holdings, Inc., a biopharmaceutical company listed...
Goldeneye 1995 Acquires Controlling Interest in Know Labs for $125 Million
Lowenstein Sandler has advised Goldeneye 1995, LLC, an affiliate of Greg Kidd. Sichenzia Ross Ference Carmel LLP has advised Know Labs, Inc. Goldeneye 1995, LLC, an...
Cyabra Strategy’s $70 Million Merger Agreement with Trailblazer Merger Corporation I
Lowenstein Sandler represented Cyabra Strategy Ltd. on the deal. Tel Aviv-based Cyabra Strategy Ltd., an AI-powered solution for combating worldwide disinformation, announced the signing of a...
First Wave BioPharma’s Acquisition of ImmunogenX
Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
DarioHealth’s Acquisition of Twill
Lowenstein Sandler represented Twill, Inc. in the transaction. DarioHealth Corp. (NASDAQ: DRIO) executed the acquisition of Twill, Inc., a leader in digital-led care. The combination enables Dario...
Timber Pharmaceuticals’ Chapter 11 and Asset Sale to Leo Pharma
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
Basic Resources’ $160 Million Acquisition of Warners, Olga, and True & Co. Businesses
Lowenstein Sandler represented PVH Corp. in the transaction. PVH Corp. (NYSE:PVH) announced an agreement to sell its Warners, Olga, and True & Co. businesses to Basic...
Static Media’s Partnership with Novacap Partners
Lowenstein represented Static Media, while Foley & Lardner LLP represented Novacap in the deal. Static Media announced its partnership with Novacap, a leading North American private equity...
Coya Therapeutics’ $15.25 Million Initial Public Offering
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics, Inc. (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory...
Dispatch’s $50 Million Series C Funding Round
Lowenstein Sandler represented PeakSpan Capital in the transaction. Dispatch completed its $50 million Series C funding round, led by PeakSpan Capital. Dispatch is a business-to-business delivery platform in which customers...
Traub Capital Partners’ Investment in HITS Shows
Lowenstein Sandler represented Traub Capital Partners in the transaction. Traub Capital Partners announced its majority investment in HITS Shows, the largest producer of hunter/jumper horse shows in...